Thank you for contacting us.
As it would seem your cancer treatment is complete and you are in remission I do not think a PARP inhibitor trial is currently appropriate for you. They are still in investigation in more advanced forms of the disease before being considered for women without evidence of active cancer.
With best wishes,
A
Prepared and sent on behalf of
Consultant Oncologist/Director
Breakthrough Breast Cancer Research Unit
King's College London School of Medicine
Research Oncology
3rd Floor Bermondsey Wing
Guy's Hospital
London SE1 9RT
Hmmmm. Pretty much what I'd been expecting really. Although disappointed, his email gave me some hope. The phrase 'before being considered for women without evidence of active cancer.' Meaning, I assume, that eventually this treatment MAY be used as an ongoing treatment for TN patients post chemo and radio. NOT that that helps me particularly but it may help my daughter.
No comments:
Post a Comment